Proteome Sciences Share Discussion Threads

[wasjobber] 22/7/2024 09:14

I wonder how high Proteome Sciences share price will rise after Randox announce the release of their clinical Stroke test in blood?

[sandcrab2] 21/7/2024 19:29

Nice bounce

Leak?

[monte1] 17/7/2024 16:40

More so than izal iirc from my schooldays.

[elpirata] 17/7/2024 16:31

particularly effective wrt the klingons iirc

[dominiccummings] 17/7/2024 15:34

Huh. Bones in Startrek had that tool years ago!

[colinhy] 17/7/2024 13:09

The results will be used to develop a portable analyser which runs all tests simultaneously, yielding results within 15 minutes that can then be used to guide the patient’s management.

[peverill] 17/7/2024 11:36

Stroke release has been imminent for 10 years!!

[barry evans] 17/7/2024 11:14

"STRONG BUY"

Oh aye.

[wasjobber] 17/7/2024 11:04

The clinical stroke trails ended last year and Dr Ian Pike has said Randox seem to think the stroke biochip test will be released by the end of this year.

So there is ever reason to think the new Randox stroke test release date is imminent.

STRONG BUY

[elpirata] 17/7/2024 10:35

Is 5 years & counting since 'launch' SPEED?

[dominiccummings] 15/7/2024 12:11

Old slippery, undoubtedly.

[barry evans] 15/7/2024 11:27

For clarity, could you confirm which you are referring to. elpirata, POTUS or old slippery?

[elpirata] 15/7/2024 08:40

elpirata 15 Jul '24 - 09:39 - 2179 of 2179 Edit
0 0 0
I note DJT Nasdaq (Trump) is already up 60% pre market, Im going to ask peverill if he could arrange to wing CJP

[peverill] 10/7/2024 06:28

How's the takeover coming along wasjobber??

[monte1] 01/7/2024 14:03

If only we could see a bit of revenue or share price creep eh?

[colinhy] 01/7/2024 14:00

In new Alzheimer’s criteria, some see progress while others fear profit-driven ‘diagnostic creep’

By Brenda Goodman, CNN Mon July 1, 2024

[wasjobber] 29/6/2024 09:41

pools2

Proteome Sciences did say in their recent 2023 annual report that they had critical intellectual property for Alzheimer's disease and cancer. The information you've provided is an important part of the regulatory AD framework and, as you suggest, very important for Proteome Sciences shareholders. Well done and many thanks.


STRONG BUY

[pools2] 29/6/2024 07:43

28 June 2024

"A work group convened by the Alzheimer's Association has released revised biology-based criteria for the diagnosis and staging of Alzheimer's disease (AD), including a new biomarker classification system that incorporates fluid and imaging biomarkers as well as an updated disease staging system."



This is very significant for Proteome Sciences, as anyone who follows them closely will know that the biomarkers listed in this new 'biomarker classification system' are covered by PRM's patents. At their recent AGM Dr Ian Pike CSO told everyone that the p-tau 217 biomarker was only valid when used with 'other' biomarkers as described in Proteome Sciences patents. Well guess what, that's is exactly how the Alzheimer's Association has just defined their new protocol for AD disease in the link above.

All biomarkers listed in this new 'biomarker classification system' are covered in Proteome Sciences Alzheimer's disease patents.

[peverill] 26/6/2024 09:27

How much is Wasjobbers take out price,give or take a bit of dilution over the years I would be happy with £36 per share.Roll on the takeover I say.

[barry evans] 25/6/2024 08:07

I confess, I rather assumed he was referring to a joint administrator.

[monte1] 25/6/2024 08:00

‘Sooner’ - that term and PRM are exceedingly unlikely bedfellows.